MAY 16, 2018 06:30 AM PDT

Ketogenic Diet Has Anti-Tumor Effects

What is up with the ketogenic diet?  Individuals struggling with their size and health have utilized it successfully to lose large amounts of weight in relatively short spans of time.  The ketogenic diet (KD) is a high-fat, low-carbohydrate, moderate-protein method of eating to utilize the body’s ability to use fat for energy, rather than using consumed glucose in multiple forms including carbohydrates.  The body enters a state of ketosis whereby body fat is burned for cellular energy and produces ketones.  After learning more about this eating method, researchers began to look at the biochemical mechanisms of this ketogenic process in the body; the impact on cells is very positive.  Healthy cells can produce ATP via oxidative phosphorylation instead of via glycolysis.  Cancerous cells, on the other hand, cannot generate energy without the glycolytic pathway and thus, do not produce the energy needed to survive in the KD environment.  The Warburg effect outlines the biochemical phenomenon where cancer cells use glycolysis to produce energy rather than alternative methods of ATP production.  It is postulated that the Warburg Effect supports the biosynthetic requirements of uncontrolled proliferation, according to Liberti and Locasale (Trends Biochem Sci, 2016).  Cancerous cells have also been shown to have an inability to process ketone bodies due to mitochondrial dysfunction.  The KD can therefore be a dietary option for cancer patients to reduce their blood glucose levels, thus starving cancerous cells of their energy source.  In addition, lowering blood glucose levels triggers lowered levels of insulin and growth factors which have been shown to be drivers in cancer progression resulting in energy depleted cancer cells with low drive to proliferate and grow.

One study published this year in the journal Aging outlined their proposal and evaluation of preclinical study data on this topic.  The literature supports the hypothesis that a KD can have an anti-tumor effect, but it may be dependent on the type of cancer involved. KD has been studied with neuroblastoma patients and been shown to reduce growth rates.  One study suggested the difficulty in utilizing a KD in some cancer patients with cachexia so proposed an alternative KD diet, termed ad libitum KD with 25% medium-chain triglycerides and 75% long-chain triglycerides produced a better anti-tumor effect.  Individual optimization may be necessary for a provider and patient based on their cancer diagnosis and tumor profile.  With the use of data analytics and computational oncology to provide toolkits and databases for tumor profiles and precision medicine suggestions, this information could also be included.

Randomized clinical trials have not been completed to evaluate this approach but of the clinical studies in the literature, results are promising and something to consider for patients.

This TedTalk is done by a researcher in Florida who is currently working on ketogenic agents and alternative energy sources to reduce cancer load. 

Sources: Aging, Trends in Biochemical Science, Redox Biology,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
JUL 22, 2018
Cell & Molecular Biology
JUL 22, 2018
Using Nanosubmarines to Fight Tumors and Headaches
Researchers are getting closer to creating targeted therapies that are delivered directly where needed....
AUG 08, 2018
Immunology
AUG 08, 2018
Doxorubicin Causes Heart Toxicity by Immune System Disruption
Chemotherapy drug Doxorubicin disrupts metabolism that controls immune responses in the heart leading to heart toxicity....
OCT 14, 2018
Immunology
OCT 14, 2018
The Stem of Cancer
Scientists reveal a pathway involved in cancer cell ability to act as stem cells...
OCT 29, 2018
Immunology
OCT 29, 2018
Escape of the Tumor Cell
Tumor cells in breast cancer have proven to evade the immune responses utilizing actin cytoskeleton...
NOV 12, 2018
Cancer
NOV 12, 2018
Targeted radiation therapy may provide new hope to children with difficult-to-treat liver cancer
Primary malignant liver tumors are rare in children with an occurrence rate of 1-2% of all childhood cancers. Radical surgical resection of the liver which means the removal of part of the li...
NOV 15, 2018
Drug Discovery
NOV 15, 2018
Making Cancer Disappear?
Neuroblastoma is one of the most common childhood cancers and the leading cause of cancer deaths among pediatric patients younger than 5. The cancer is fre...
Loading Comments...